Matthew Powell

2025

Challenges in implementation of molecular classification in early stage endometrial cancer—An NRG Oncology cooperative group mixed-methods study

Wilson, E. M., Huang, R., Jones, K. D., Hagemann, I. S., Temkin, S. M., McAlpine, J. N., Powell, M. A., Kepper, M. M. & Hagemann, A. R., Jan 1 2025, In: Cancer. 131, 1, e35596.

Research output: Contribution to journal › Article › peer-review

Open Access

Efficacy and safety of dostarlimab in combination with chemotherapy in patients with dMMR/MSI-H primary advanced or recurrent endometrial cancer in a phase 3, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY)

Powell, M. A., Cibula, D., O'Malley, D. M., Boere, I., Shahin, M. S., Savarese, A., Chase, D. M., Gilbert, L., Black, D., Herrstedt, J., Sharma, S., Kommoss, S., Gold, M. A., Thijs, A. M., Ring, K., Bolling, M. F., Buscema, J., Gill, S. E., Nowicki, P. & Nevadunsky, N. & 10 others, Callahan, M., Willmott, L., McCourt, C., Billingsley, C., Ghamande, S. A., He, Z., Balas, M. M., Stevens, S., Fleming, E. & Mirza, M. R., Jan 2025, In: Gynecologic oncology. 192, p. 40-49 10 p.

Research output: Contribution to journal › Article › peer-review

Open Access

Molecular classification of endometrial cancers (EC) and association with relapse-free survival (RFS) and overall survival (OS) outcomes: Ancillary analysis of GOG-0258

Clements, A., Enserro, D., Strickland, K. C., Previs, R., Matei, D., Mutch, D., Powell, M., Klopp, A., Miller, D. S., Small, W., DiSilvestro, P., Spirtos, N., Cosgrove, C., Sfakianos, G., Liu, J. R., Vargas, R., Shahin, M., Corr, B., Dessources, K. & Ueland, F. & 3 others, Warshal, D., Gillen, J. & Secord, A. A., Feb 2025, In: Gynecologic oncology. 193, p. 119-129 11 p.

Research output: Contribution to journal › Article › peer-review

Not all uterine carcinosarcomas are created equal: Survival outcomes according to molecular characterization of uterine carcinosarcoma

Toboni, M. D., Dinkins, K., Wu, S., Mattox, T., Oberley, M. J., Thaker, P. H., Herzog, T. J., Powell, M. & Jones, N., Feb 2025, In: Gynecologic oncology. 193, p. 89-97 9 p.

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

2024

Accuracy of surveillance serum squamous cell carcinoma antigen for cervical cancer recurrence after definitive chemoradiation

Shi, V., Grover, S., Huang, Y., Thaker, P. H., Kuroki, L. M., Powell, M. A., Mutch, D. G., Contreras, J. A., Schwarz, J. K., Grigsby, P. W. & Markovina, S., Jun 1 2024, In: International Journal of Gynecological Cancer. 34, 6, p. 808-816 9 p.

Research output: Contribution to journal › Article › peer-review

Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer

Bogani, G., Monk, B. J., Powell, M. A., Westin, S. N., Slomovitz, B., Moore, K. N., Eskander, R. N., Raspagliesi, F., Barretina-Ginesta, M. P., Colombo, N. & Mirza, M. R., May 2024, In: Annals of Oncology. 35, 5, p. 414-428 15 p.

Research output: Contribution to journal › Review article › peer-review

30 Scopus citations

A Plain Language Summary of “Dostarlimab for primary advanced or recurrent endometrial cancer”

Mirza, M. R., Chase, D. M., Slomovitz, B. M., Christensen, R. D. P., Novák, Z., Black, D., Gilbert, L., Sharma, S., Valabrega, G., Landrum, L. M., Hanker, L. C., Stuckey, A., Boere, I., Gold, M. A., Auranen, A., Pothuri, B., Cibula, D., McCourt, C., Raspagliesi, F. & Shahin, M. S. & 11 others, Gill, S. E., Monk, B. J., Buscema, J., Herzog, T. J., Copeland, L. J., Tian, M., He, Z., Stevens, S., Zografos, E., Coleman, R. L. & Powell, M. A., 2024, (Accepted/In press) In: Future Oncology.

Research output: Contribution to journal › Article › peer-review

A toolkit for a modern gynecologic oncology tissue bank

Graham, O., Rodriguez, J., Abbott, R., Lomonosova, E., Fashemi, B., Drexler, R., Grither, W., Rodriguez, K., Compadre, A., Loeb, M., Sanders, B., Kuroki, L., Hagemann, A. R., McCourt, C., Thaker, P. H., Fuh, K., Powell, M. A., Hagemann, I. S., Mutch, D. G. & Khabele, D. & 1 others, Mullen, M. M., Oct 2024, In: Gynecologic oncology. 189, p. 1-8 8 p.

Research output: Contribution to journal › Article › peer-review

Attack of the clones: Unveiling subclonal/heterogenous mismatch repair/microsatellite instability status in endometrial cancer

Grither, W. R., Hagemann, I. S., Powell, M. A. & Mullen, M. M., Feb 1 2024, In: Cancer. 130, 3, p. 339-341 3 p.

Research output: Contribution to journal › Editorial

Cediranib and Olaparib Combination Compared with Cediranib or Olaparib Alone, or Chemotherapy in Platinum-Resistant or Primary Platinum-Refractory Ovarian Cancer: NRG-GY005

Lee, J. M., Brady, M. F., Miller, A., Moore, R. G., MacKay, H., McNally, L., Lea, J., Street, D., Lheureux, S., McDonald, M. E., Duska, L. R., Cantuaria, G., Kavecansky, J., Leath, C. A., Powell, M., Cadungog, M. G., Rose, P. G., Kim, Y. M., Huang, H. Q. & Provencher, M. & 4 others, Wenzel, L. B., Bookman, M. A., Kohn, E. C. & Secord, A. A., Dec 20 2024, In: Journal of Clinical Oncology. 42, 36, p. 4305-4316 12 p.

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Clinical research in endometrial cancer: consensus recommendations from the Gynecologic Cancer InterGroup

participants of the 2023 Gynecologic Cancer InterGroup Endometrial Cancer Consensus Conference on Clinical Research, Sep 2024, In: The Lancet Oncology. 25, 9, p. e420-e431

Research output: Contribution to journal › Review article › peer-review

5 Scopus citations

Differential Responses to Immune Checkpoint Inhibitors are Governed by Diverse Mismatch Repair Gene Alterations

Khushman, M. M., Toboni, M. D., Xiu, J., Manne, U., Farrell, A., Lou, E., Shields, A. F., Philip, P. A., Salem, M. E., Abraham, J., Spetzler, D., Marshall, J., Jayachandran, P., Hall, M. J., Lenz, H. J., Sahin, I. H., Seeber, A. & Powell, M. A., May 1 2024, In: Clinical Cancer Research. 30, 9, p. 1906-1915 10 p.

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Disease progression, survival, and molecular disparities in Black and White patients with endometrioid endometrial carcinoma in real-world registries and GOG/NRG oncology randomized phase III clinical trials

Kopelman, Z. A., Tian, C., Tumas, J., Phippen, N. T., Tarney, C. M., Hope, E. R., Winkler, S. S., Jokajtys, S., Kucera, C. W., Chan, J. K., Richardson, M. T., Kapp, D. S., Hamilton, C. A., Leath, C. A., Jones, N. L., Rocconi, R. P., Farley, J. H., Secord, A. A., Cosgrove, C. M. & Powell, M. A. & 7 others, Klopp, A., Walker, J. L., Fleming, G. F., Bateman, N. W., Conrads, T. P., Maxwell, G. L. & Darcy, K. M., Apr 2024, In: Gynecologic oncology. 183, p. 103-114 12 p.

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Endometrial Cancer: Updates in Molecular Characterization and Treatment Opportunities

Powell, M. & Vetter, M., 2024, In: Healthbook TIMES Oncology Hematology. 19, 1, p. 56-61 6 p.

Research output: Contribution to journal › Review article › peer-review

Open Access

1 Scopus citations

Evolving Treatment Landscape in Endometrial Cancer

Vetter, M. & Powell, M. A., 2024, In: Healthbook TIMES Oncology Hematology. 20, 2, p. 40-47 8 p.

Research output: Contribution to journal › Review article › peer-review

Open Access

Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of Chemoradiation Versus Chemotherapy for Locally Advanced Endometrial Carcinoma

Matei, D. E., Enserro, D. M., Randall, M. E., Mutch, D., Small, W., Disilvestro, P. A., Spirtos, N. M., O'malley, D. M., Cantuaria, G. H., Michelin, D., Waggoner, S., Shahin, M., Guntupalli, S., Lara, O., Ueland, F. R., Warshal, D., Bonebrake, A., Tewari, K. S., Tan, A. & Powell, M. & 4 others, Walker, J. L., Santin, A. D., Kim, J. H. & Miller, D. S., 2024, (Accepted/In press) In: Journal of Clinical Oncology.

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Nonendometrioid Endometrial Carcinomas and Uterine Sarcomas

Powell, M. A., Jan 1 2024, Textbook of Uncommon Cancer: Fifth Edition. wiley, p. 591-617 27 p.

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

NRG-GY012: Randomized phase 2 study comparing olaparib, cediranib, and the combination of cediranib/olaparib in women with recurrent, persistent, or metastatic endometrial cancer

Rimel, B. J., Enserro, D., Bender, D. P., Jackson, C. G., Tan, A., Alluri, N., Borowsky, M., Moroney, J., Hendrickson, A. W., Backes, F., Swisher, E., Powell, M. & MacKay, H., Apr 15 2024, In: Cancer. 130, 8, p. 1234-1245 12 p.

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Overall survival in patients with endometrial cancer treated with dostarlimab plus carboplatin–paclitaxel in the randomized ENGOT-EN6/GOG-3031/RUBY trial

Powell, M. A., Bjørge, L., Willmott, L., Novák, Z., Black, D., Gilbert, L., Sharma, S., Valabrega, G., Landrum, L. M., Gropp-Meier, M., Stuckey, A., Boere, I., Gold, M. A., Segev, Y., Gill, S. E., Gennigens, C., Sebastianelli, A., Shahin, M. S., Pothuri, B. & Monk, B. J. & 11 others, Buscema, J., Coleman, R. L., Slomovitz, B. M., Ring, K. L., Herzog, T. J., Balas, M. M., Grimshaw, M., Stevens, S., Lai, D. W., McCourt, C. & Mirza, M. R., Aug 2024, In: Annals of Oncology. 35, 8, p. 728-738 11 p.

Research output: Contribution to journal › Article › peer-review

Open Access

19 Scopus citations

Patient-reported outcomes in the subpopulation of patients with mismatch repair-deficient/microsatellite instability-high primary advanced or recurrent endometrial cancer treated with dostarlimab plus chemotherapy compared with chemotherapy alone in the ENGOT-EN6-NSGO/GOG3031/RUBY trial

Valabrega, G., Powell, M. A., Hietanen, S., Miller, E. M., Novak, Z., Holloway, R., Denschlag, D., Myers, T., Thijs, A. M., Pennington, K. P., Gilbert, L., Fleming, E., Zub, O., Landrum, L. M., Ataseven, B., Gogoi, R., Podzielinski, I., Cloven, N., Monk, B. J. & Sharma, S. & 10 others, Herzog, T. J., Stuckey, A., Pothuri, B., Secord, A. A., Chase, D., Vincent, V., Meyers, O., Garside, J., Mirza, M. R. & Black, D., 2024, (Accepted/In press) In: International Journal of Gynecological Cancer. ijgc-2024-005484.

Research output: Contribution to journal › Article › peer-review

Open Access

Primary results and characterization of patients with exceptional outcomes in a phase 1b study combining PARP and MEK inhibition, with or without anti–PD-L1, for BRCA wild-type, platinum-sensitive, recurrent ovarian cancer

Mutch, D., Voulgari, A., Chen, X., Bradley, W. H., Oaknin, A., Perez Fidalgo, J. A., Montosa, F. G., Herraez, A. C., Holloway, R. W., Powell, M. A., Nowicka, M., Schaefer, G., Merchant, M. & Yan, Y., Jun 1 2024, In: Cancer. 130, 11, p. 1940-1951 12 p.

Research output: Contribution to journal › Article › peer-review

Open Access

2 Scopus citations

Prophylactic antibiotics for excision of premalignant vulvar lesions: A pilot randomized controlled trial

Mullen, M., Grither, W. R., Millimet, H., Mutch, D., Hagemann, A., McCourt, C., Powell, M., H.Thaker, P., Khabele, D. & Kuroki, L. M., Oct 2024, In: Gynecologic Oncology Reports. 55, 101476.

Research output: Contribution to journal › Article › peer-review

Open Access

Racial, ethnic and country of origin disparities in aggressive endometrial cancer histologic subtypes

Winkler, S. S., Tian, C., Casablanca, Y., Bateman, N. W., Jokajtys, S., Kucera, C. W., Tarney, C. M., Chan, J. K., Richardson, M. T., Kapp, D. S., Liao, C. I., Hamilton, C. A., Leath, C. A., Reddy, M., Cote, M. L., O'Connor, T. D., Jones, N. L., Rocconi, R. P., Powell, M. A. & Farley, J. & 5 others, Shriver, C. D., Conrads, T. P., Phippen, N. T., Maxwell, G. L. & Darcy, K. M., May 2024, In: Gynecologic oncology. 184, p. 31-42 12 p.

Research output: Contribution to journal › Article › peer-review

Radiation Therapy with or Without Cisplatin for Local Recurrences of Endometrial Cancer: Results from an NRG Oncology/GOG Prospective Randomized Multicenter Clinical Trial

Klopp, A. H., Enserro, D., Powell, M., Randall, M., Schink, J. C., Mannel, R. S., Holman, L., Bender, D., Kushnir, C. L., Backes, F., Zweizig, S. L., Waggoner, S., Bradley, K. A., Lawrence, L. D., Hanjani, P., Darus, C. J., Small, W., Cardenes, H. R., Feddock, J. M. & Miller, D. S., Jul 10 2024, In: Journal of Clinical Oncology. 42, 20, p. 2425-2435 11 p.

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Results of a randomized phase II trial of paclitaxel and carboplatin versus bleomycin, etoposide and cisplatin for newly diagnosed and recurrent Chemonaive stromal ovarian tumors: An NRG oncology/gynecologic oncology group study14

Brown, J., Miller, A., Holman, L. L., Backes, F., Nagel, C., Bender, D., Miller, D. S., Powell, M. A., Westin, S. N., Bonebrake, A., Muller, C. Y., Secord, A. A., Crane, E., Schorge, J., Tew, W. P., Sood, A. K., Bookman, M. A., Aghajanian, C. & Gershenson, D. M., Nov 2024, In: Gynecologic oncology. 190, p. 283-290 8 p.

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Safety of dostarlimab in combination with chemotherapy in patients with primary advanced or recurrent endometrial cancer in a phase III, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY)

Auranen, A., Powell, M. A., Sukhin, V., Landrum, L. M., Ronzino, G., Buscema, J., Bauerschlag, D., Lalisang, R., Bender, D., Gilbert, L., Armstrong, A., Safra, T., Nevadunsky, N., Sebastianelli, A., Slomovitz, B., Ring, K., Coleman, R., Podzielinski, I., Stuckey, A. & Teneriello, M. & 9 others, Gill, S., Pothuri, B., Willmott, L., Sharma, S., Dabrowski, C., Antony, G., Stevens, S., Mirza, M. R. & Fleming, E., Jan 1 2024, In: Therapeutic Advances in Medical Oncology. 16

Research output: Contribution to journal › Article › peer-review

Open Access

The novel drug candidate S2/IAPinh improves survival in models of pancreatic and ovarian cancer

Hagi, T., Vangveravong, S., Takchi, R., Gong, Q., Goedegebuure, S. P., Tiriac, H., Van Tine, B. A., Powell, M. A., Hawkins, W. G. & Spitzer, D., Dec 2024, In: Scientific reports. 14, 1, 6373.

Research output: Contribution to journal › Article › peer-review

Open Access

Top advances of the year: Uterine cancer

Erickson, B. K., Slomovitz, B., Powell, M. & Eskander, R. N., Jul 15 2024, In: Cancer. 130, 14, p. 2409-2412 4 p.

Research output: Contribution to journal › Comment/debate

1 Scopus citations

2023

Adenocarcinoma of the uterine corpus and sarcomas of the uterus

Creasman, W. T., Miller, D. S., Eskander, R. N. & Powell, M., Jan 1 2023, DiSaia and Creasman Clinical Gynecologic Oncology. Elsevier, p. 125-174 50 p.

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor-Positive Ovarian Cancer (Study 006)

Tanyi, J. L., Randall, L. M., Chambers, S. K., Butler, K. A., Winer, I. S., Langstraat, C. L., Han, E. S., Vahrmeijer, A. L., Chon, H. S., Morgan, M. A., Powell, M. A., Tseng, J. H., Lopez, A. S. & Wenham, R. M., Jun 2023, In: Obstetrical and Gynecological Survey. 78, 6, p. 341-342 2 p.

Research output: Contribution to journal › Comment/debate

A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor-Positive Ovarian Cancer (Study 006)

Tanyi, J. L., Randall, L. M., Chambers, S. K., Butler, K. A., Winer, I. S., Langstraat, C. L., Han, E. S., Vahrmeijer, A. L., Chon, H. S., Morgan, M. A., Powell, M. A., Tseng, J. H., Lopez, A. S. & Wenham, R. M., Jan 10 2023, In: Journal of Clinical Oncology. 41, 2, p. 276-284 9 p.

Research output: Contribution to journal › Article › peer-review

75 Scopus citations

Characterization of adnexal lesions using photoacoustic imaging to improve sonographic O-RADS risk assessment

Zhu, Q., Luo, H., Middleton, W. D., Itani, M., Hagemann, I. S., Hagemann, A. R., Hoegger, M. J., Thaker, P. H., Kuroki, L. M., MCourt, C. K., Mutch, D. G., Powell, M. A. & Siegel, C. L., Dec 2023, In: Ultrasound in Obstetrics and Gynecology. 62, 6, p. 891-903 13 p.

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Differential outcomes and immune checkpoint inhibitor response among endometrial cancer patients with MLH1 hypermethylation versus MLH1 “Lynch-like” mismatch repair gene mutation

Toboni, M. D., Wu, S., Farrell, A., Xiu, J., Ribeiro, J. R., Oberley, M. J., Arend, R., Erickson, B. K., Herzog, T. J., Thaker, P. H. & Powell, M. A., Oct 2023, In: Gynecologic oncology. 177, p. 132-141 10 p.

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.

Mirza, M. R., Chase, D. M., Slomovitz, B. M., Depont Christensen, R., Novák, Z., Black, D., Gilbert, L., Sharma, S., Valabrega, G., Landrum, L. M., Hanker, L. C., Stuckey, A., Boere, I., Gold, M. A., Auranen, A., Pothuri, B., Cibula, D., McCourt, C., Raspagliesi, F. & Shahin, M. S. & 11 others, Gill, S. E., Monk, B. J., Buscema, J., Herzog, T. J., Copeland, L. J., Tian, M., He, Z., Stevens, S., Zografos, E., Coleman, R. L. & Powell, M. A., 2023, In: New England Journal of Medicine. 388, 23, p. 2145-2158 14 p.

Research output: Contribution to journal › Article › peer-review

Open Access

376 Scopus citations

Genetic characterization of primary and metastatic high-grade serous ovarian cancer tumors reveals distinct features associated with survival

Kotnik, E. N., Mullen, M. M., Spies, N. C., Li, T., Inkman, M., Zhang, J., Martins-Rodrigues, F., Hagemann, I. S., McCourt, C. K., Thaker, P. H., Hagemann, A. R., Powell, M. A., Mutch, D. G., Khabele, D., Longmore, G. D., Mardis, E. R., Maher, C. A., Miller, C. A. & Fuh, K. C., Dec 2023, In: Communications Biology. 6, 1, 688.

Research output: Contribution to journal › Article › peer-review

Open Access

13 Scopus citations

HER2+ endometrioid endometrial cancer possesses distinct molecular and immunologic features associated with a more active immune microenvironment and worse prognosis

Bruce, S. F., Wu, S., Ribeiro, J. R., Farrell, A., Oberley, M. J., Winer, I., Erickson, B. K., Klc, T., Jones, N. L., Thaker, P. H. & Powell, M. A., May 2023, In: Gynecologic oncology. 172, p. 98-105 8 p.

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Lifestyle intervention in ovarian cancer enhanced survival (LIVES) study (NRG/GOG0225): Recruitment, retention and baseline characteristics of a randomized trial of diet and physical activity in ovarian cancer survivors

Thomson, C. A., Crane, T. E., Miller, A., Gold, M. A., Powell, M., Bixel, K., Van Le, L., DiSilvestro, P., Ratner, E., Lele, S., Guntupalli, S., Huh, W., Robertson, S. E., Modesitt, S., Casey, A. C., Basen-Engquist, K., Skiba, M., Walker, J., Kachnic, L. & Alberts, D. S., Mar 2023, In: Gynecologic oncology. 170, p. 11-18 8 p.

Research output: Contribution to journal › Article › peer-review

Open Access

11 Scopus citations

Mixed clear cell/endometrioid and clear cell/serous carcinoma of the uterus are clinicopathologically similar to pure clear cell carcinoma: An NRG Oncology/Gynecologic Oncology Group (GOG-210) study of 311 women

Hagemann, I. S., Deng, W., Zaino, R. J., Powell, M. A., Gunderson Jackson, C., Cosgrove, C., Mathews, C., Pearl, M. L., Waggoner, S., Ghebre, R., Lele, S., Guntupalli, S., Secord, A. A., Ioffe, O., Rasty, G., Singh, M., Soslow, R., Creasman, W. & Mutch, D. G., Oct 2023, In: Gynecologic oncology. 177, p. 38-45 8 p.

Research output: Contribution to journal › Article › peer-review

Open Access

3 Scopus citations

PD-1 and PD-L1 Blockade plus Chemotherapy in Endometrial Cancer. Reply

Mirza, M. R. & Powell, M. A., Aug 31 2023, In: The New England journal of medicine. 389, 9, p. 867 1 p.

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer

Eskander, R. N., Sill, M. W., Beffa, L., Moore, R. G., Hope, J. M., Musa, F. B., Mannel, R., Shahin, M. S., Cantuaria, G. H., Girda, E., Mathews, C., Kavecansky, J., Leath, C. A., Gien, L. T., Hinchcliff, E. M., Lele, S. B., Landrum, L. M., Backes, F., O'Cearbhaill, R. E. & Al Baghdadi, T. & 7 others, Hill, E. K., Thaker, P. H., John, V. S., Welch, S., Fader, A. N., Powell, M. A. & Aghajanian, C., 2023, In: New England Journal of Medicine. 388, 23, p. 2159-2170 12 p.

Research output: Contribution to journal › Article › peer-review

Open Access

319 Scopus citations

Pembrolizumab Plus Chemotherapy in Advanced Endometrial Cancer

Eskander, R. N., Sill, M. W., Beffa, L., Moore, R. G., Hope, J. M., Musa, F. B., Mannel, R., Shahin, M. S., Cantuaria, G. H., Girda, E., Mathews, C., Kavecansky, J., Leath, C. A., Gien, L. T., Hinchcliff, E. M., Lele, S. B., Landrum, L. M., Backes, F., O'cearbhaill, R. E. & Al Baghdadi, T. & 7 others, Hill, E. K., Thaker, P. H., John, V. S., Welch, S., Fader, A. N., Powell, M. A. & Aghajanian, C., Jul 1 2023, In: Obstetrical and Gynecological Survey. 78, 7, p. 406-407 2 p.

Research output: Contribution to journal › Comment/debate

Open Access

1 Scopus citations

RAD51 Foci as a Biomarker Predictive of Platinum Chemotherapy Response in Ovarian Cancer

Compadre, A. J., van Biljon, L. N., Valentine, M. C., Llop-Guevara, A., Graham, E., Fashemi, B., Herencia-Ropero, A., Kotnik, E. N., Cooper, I., Harrington, S. P., Kuroki, L. M., McCourt, C. K., Hagemann, A. R., Thaker, P. H., Mutch, D. G., Powell, M. A., Sun, L., Mosammaparast, N., Serra, V. & Zhao, P. & 3 others, Lomonosova, E., Khabele, D. & Mullen, M. M., Jul 1 2023, In: Clinical Cancer Research. 29, 13, p. 2466-2479 14 p.

Research output: Contribution to journal › Article › peer-review

Open Access

27 Scopus citations

Stromal DDR2 Promotes Ovarian Cancer Metastasis through Regulation of Metabolism and Secretion of Extracellular Matrix Proteins

Schab, A. M., Greenwade, M. M., Stock, E., Lomonosova, E., Cho, K., Grither, W. R., Noia, H., Wilke, D., Mullen, M. M., Hagemann, A. R., Hagemann, I. S., Thaker, P. H., Kuroki, L. M., McCourt, C. K., Khabele, D., Powell, M. A., Mutch, D. G., Zhao, P., Shriver, L. P. & Patti, G. J. & 2 others, Longmore, G. D. & Fuh, K. C., 2023, In: Molecular Cancer Research. 21, 11, p. 1234-1248 15 p.

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Two-year follow up on the impact of the COVID-19 pandemic on outcomes in gynecologic oncology patients

Turner, K., Bruce, S., Carbonell, K. V., Mullen, M. M., Hagemann, A. R., McCourt, C., Thaker, P., Khabele, D., Powell, M. A., Mutch, D. G. & Kuroki, L., Aug 2023, In: Gynecologic Oncology Reports. 48, p. S37

Research output: Contribution to journal › Conference article › peer-review

Open Access

2022

Community access to primary care is an important geographic disparity among ovarian cancer patients undergoing cytoreductive surgery

Zamorano, A. S., Mazul, A. L., Marx, C., Mullen, M. M., Greenwade, M., Stewart Massad, L., McCourt, C. K., Hagemann, A. R., Thaker, P. H., Fuh, K. C., Powell, M. A., Mutch, D. G., Khabele, D. & Kuroki, L. M., Dec 2022, In: Gynecologic Oncology Reports. 44, 101075.

Research output: Contribution to journal › Article › peer-review

Open Access

Conditional estimates for uterine serous cancer: Tools for survivorship counseling and planning

Nolin, A. C., Tian, C., Hamilton, C. A., Casablanca, Y., Bateman, N. W., Chan, J. K., Cote, M. L., Shriver, C. D., Powell, M. A., Phippen, N. T., Conrads, T. P., Maxwell, G. L. & Darcy, K. M., Jul 2022, In: Gynecologic oncology. 166, 1, p. 90-99 10 p.

Research output: Contribution to journal › Article › peer-review

GAS6/AXL Inhibition Enhances Ovarian Cancer Sensitivity to Chemotherapy and PARP Inhibition through Increased DNA Damage and Enhanced Replication Stress

Mullen, M. M., Lomonosova, E., Toboni, M. D., Oplt, A., Cybulla, E., Blachut, B., Zhao, P., Noia, H., Wilke, D., Rankin, E. B., Kuroki, L. M., Hagemann, A. R., Hagemann, I. S., McCourt, C. K., Thaker, P. H., Mutch, D. G., Powell, M. A., Mosammaparast, N., Vindigni, A. & Fuh, K., Feb 2022, In: Molecular Cancer Research. 20, 2, p. 265-279 15 p.

Research output: Contribution to journal › Article › peer-review

Open Access

31 Scopus citations

GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

Bruce, S. F., Cho, K., Noia, H., Lomonosova, E., Stock, E. C., Oplt, A., Blachut, B., Mullen, M. M., Kuroki, L. M., Hagemann, A. R., McCourt, C. K., Thaker, P. H., Khabele, D., Powell, M. A., Mutch, D. G., Shriver, L. P., Patti, G. J. & Fuh, K., Aug 2022, In: Molecular Cancer Therapeutics. 21, 8, p. 1348-1359 12 p.

Research output: Contribution to journal › Article › peer-review

Open Access

7 Scopus citations

Gynecologic oncology patient perspectives and knowledge on advance care planning: A quality improvement intervention

Huepenbecker, S. P., Lewis, S., Valentine, M. C., Palisoul, M. L., Thaker, P. H., Hagemann, A. R., McCourt, C. K., Fuh, K., Powell, M. A., Mutch, D. G. & Kuroki, L. M., Oct 2022, In: Gynecologic Oncology Reports. 43, 101060.

Research output: Contribution to journal › Article › peer-review

Open Access

1 Scopus citations

HER2 in Uterine Serous Carcinoma: Testing platforms and implications for targeted therapy

Klc, T. R., Wu, S., Wilhite, A. M., Jones, N. L., Powell, M. A., Olawaiye, A., Girda, E., Brown, J., Puechl, A., Ali-Fehmi, R., Winer, I. S., Herzog, T. J., Korn, W. M. & Erickson, B. K., Nov 2022, In: Gynecologic oncology. 167, 2, p. 289-294 6 p.

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Matthew Powell

Research output

Search results